University of California San Francisco
Give to UCSF
Displaying 2191 - 2220 of 16347
-
-
Hospital Alarms Torment Patients
-
Experts Say Solutions to Homelessness Known, Require Commitment
-
Deportation fears linked to high blood pressure among immigrant women
-
Abolish race-based medicine in kidney disease and beyond
-
Newborn Immune System Detects Harmful Skin Bacteria
UCSF scientists found that an early-life window of immune tolerance available to a normally harmless bacterial species is firmly closed to another, often pathogenic species — one that is a leading cause of drug-resistant skin infections in the U.S. and occasional source of “flesh-eating” necrosis.
-
UC Regents Approve Plans, Funding for New Research and Academic Building at ZSFG
A rendering of the new research building at Zuckerberg San Francisco General Hospital, as viewed form the 23rd Street entrance to the medical center campus. UC San Francisco is moving forward with
-
Psychedelic Drugs Get a Second Look, As Therapy for PTSD
-
Nurses Take to the Streets in Homeless Outreach
-
This Doctor Wants to Use Salesforce Blockchain to Cut Cancer Drug Development Costs in Half
-
How the Brain Detects the Rhythms of Speech
Neuroscientists discovered how the listening brain scans speech to break it down into syllables. The findings provide for the first time a neural basis for the fundamental atoms of language and insights into our perception of the rhythmic poetry of speech.
-
The Loudness Of Vowels Helps The Brain Break Down Speech Into Syl-La-Bles
-
Will Science Ever Give Us a Better Night’s Sleep?
-
Many Patients with Anorexia Nervosa Get Better, But Complete Recovery Elusive to Most
Three in four patients with anorexia nervosa make a partial recovery. But just 21 percent make a full recovery, a milestone that is most likely to signal permanent remission.
-
Amid vape epidemic, Marin researcher sheds light on e-cigarette waste
-
‘Supergrowth’ Challenges Established Science of Cell Growth
Research shows that after cells are subjected to certain stressful treatments, they appear to gain a new “superpower” that allows them to grow twice as fast as normal — a feature the authors call “supergrowth.”
-
Progress Update: UC Addresses Concerns with Health Service Agreements
The University of California is providing this update on efforts to address concerns about its agreements with non-UC medical facilities, including faith-based healthcare facilities.
-
In Down Syndrome Mouse Model, Scientists Reverse Intellectual Deficits with Drugs
Using standard animal model of Down syndrome, scientists were able to correct the learning and memory deficits associated with the condition with drugs that target the body’s response to cellular stresses.
-
We Know We’re Full Because Intestine’s Stretch Sensors Tell Us So
We commonly think a full stomach is what tells us to stop eating, but it may be that a stretched intestine plays an even bigger role in making us feel sated.
-
Researchers Halt Spread of Breast Cancer by Blocking Metastasis-Promoting Enzyme
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UCSF scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.
-
2019 Diversity Awards Honor Outstanding Efforts to Advance Diversity, Equity and Inclusion
The faculty, staff and students were honored by Chancellor Sam Hawgood, MBBS, and Vice Chancellor Renee Chapman Navarro, MD, PharmD, during a luncheon on Oct. 24.
-
Conflict of Interest Statements Don’t Affect Peer Review
New study reveals that peer reviewers do not take conflicts of interest disclosures into account in their recommendations to journal editors, likely because of an absence of clear guidelines on how conflicts should impact their evaluations.
-
Sandy and Joan Weill donate $106M for brain research at UCSF, UC Berkeley, UW
-
Sandy and Joan Weill donate $106M for brain research at UCSF, UC Berkeley, UW
-
Weill Neurohub Will Unite UCSF, UC Berkeley, U. of Washington to Find New Treatments for Brain Diseases
With a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco, and the University of Washington have launched the Weill Neurohub to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.
-
The Science Is Extremely Clear: You Need to Prioritize Sleep
-
New York’s Jails Are Failing. Is the Answer 3,600 Miles Away?
-
Pregnant people are being offered an unproven treatment to “reverse” abortions
-
U.S. Supreme Court Takes on DACA – and Fate of Nearly 200,000 California Dreamers
-
‘Basket’ Trials for Dementia Aim to Bring Precision Medicine to Neurogenerative Diseases
Adam L. Boxer answers questions about the potential of "basket trials" to accelerate drug development for dementia and neurodegenerative disease.
